Sotagliflozin is an active pharmaceutical ingredient that functions as a dual SGLT-1 and SGLT-2 inhibitor. Its significance lies in its application as a pharmaceutical raw material for manufacturing medications used in metabolic disorder research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1018899-04-1
Dapagliflozin Impurity D
pharmaceutical intermediate
Dapagliflozin
pharmaceutical raw material
Dapagliflozin propanediol hydrate
pharmaceutical raw material
N-demethyltramadol hydrochloride
pharmaceutical raw material
Regorafenib monohydrate
pharmaceutical raw material
Sulfaclozine
pharmaceutical raw material
Benzamidenafil
pharmaceutical raw material
Beta-L-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, 2,3,4-triacetate, (5S)-
research compound
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol
QKDRXGFQVGOQKS-CRSSMBPESA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl